International Journal of COPD · 2020 · 25 citations · 20 references
MedicineInternal MedicineEpidemiologyInflammationPulmonologyChronic Obstructive Pulmonary DiseaseEosinophilic DisordersObstructive Lung DiseaseRespiratory DiseaseChronic Obstructive Pulmonary Disease AssessmentChronic Obstructive Pulmonary Disease InflammationChronic Obstructive Pulmonary Disease PathophysiologyEosinophil BiomarkersEosinophil CountExacerbation Risk StratificationExacerbation Severity AssessmentPulmonary Exacerbations
Purpose: Blood eosinophil is a readily available biomarker to reflect the eosinophilic inflammation in chronic obstructive pulmonary disease (COPD) patients, yet its association with exacerbation is inconclusive. It is uncertain which measurement, eosinophil percentage or absolute eosinophil count, should be used and what is the optimal cutoff for exacerbation prediction. Patients and Methods: A total of 247 COPD patients were included in this retrospective cohort study. Blood eosinophil during stable disease state, baseline demographics, and clinical characteristics in 12 months after the index complete blood count (CBC) were recorded. Exacerbation frequencies were compared between patients with high and low blood eosinophil percentage using 2% as cut-off. Logistic regression and receiver operating characteristics (ROC) curve analyses were conducted. Results: Patients with blood eosinophil ≥2% were associated with more frequent exacerbations than patients with eosinophil <2% in the 12 months after the index CBC (mean exacerbation 1.07 vs 0.34, p < 0.001). Higher blood eosinophil percentage conferred a higher risk of exacerbation. Adjusted odds ratio for exacerbation in 12 months after the index CBC for blood eosinophil ≥2% was 2.98 (95% confidence interval = 1.42-6.25). The area under the ROC curve of eosinophil percentage was significantly higher than that of absolute eosinophil count (0.678 vs 0.640, p = 0.010). The optimal cutoff of blood eosinophil percentage for exacerbation prediction was 2.8%. Conclusion: Blood eosinophilia was associated with higher exacerbation risk in COPD patients. Further studies are required to elucidate the mechanism of eosinophilic inflammation in COPD and determine the optimal treatment strategy to reduce exacerbations.
20
Index for rating diagnostic tests
W. J. Youden · Cancer · 1950 · 11.5K citations · Full text
Education, Educational Assessment, Educational Measurement +11
Mona Bafadhel, Susan McKenna, Sarah Terry et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 1.1K citations
Steven Pascoe, Nicholas Locantore, Mark T. Dransfield et al. · The Lancet Respiratory Medicine · 2015 · 733 citations
Signe Vedel‐Krogh, Sune F. Nielsen, Peter Lange et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 428 citations